FORTE BIOSCIENCES INC (FBRX) Stock Price, Quote, News and Overview
NASDAQ:FBRX - Nasdaq - US34962G2084 - Common Stock - Currency: USD
FBRX Quote, Performance and Key Statistics
6.5
-0.51 (-7.28%)
The current stock price of FBRX is 6.5 USD. In the past month the price decreased by -50%. In the past year, price decreased by -65.66%.
FBRX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.17 | 378.30B | ||
| AMGN | AMGEN INC | 16.39 | 174.51B | ||
| GILD | GILEAD SCIENCES INC | 25.47 | 146.22B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1683.76 | 125.39B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.5 | 77.34B | ||
| ARGX | ARGENX SE - ADR | 231.21 | 36.10B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 31.66B | ||
| ONC | BEIGENE LTD-ADR | N/A | 26.47B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.08B | ||
| BIIB | BIOGEN INC | 9.13 | 22.01B | ||
| NTRA | NATERA INC | N/A | 19.02B | ||
| GMAB | GENMAB A/S -SP ADR | 24.89 | 15.34B |
Related stock screener links
About FBRX
Company Profile
Forte Biosciences Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Dallas, Texas and currently employs 11 full-time employees. The company went IPO on 2017-04-13. Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases. The firm is advancing its product candidate, FB-102, which is a proprietary molecule with potentially broad autoimmune applications, including in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA). The Company’s FB-102 program focuses on addressing key pathways implicated in these indications with a CD122 antagonist. CD122 is a subunit of IL-2/IL-15 receptors which are key regulators of NK cells and T cell subsets. The company owns one United States patent for administering a combination of Gram-positive and Gram-negative bacteria along with metabolites for treatment of a wide variety of skin conditions. The Company’s subsidiaries include Forte Subsidiary, Inc., Forte Biosciences Emerald Limited, and Forte Biosciences Australia Pty Ltd.
Company Info
FORTE BIOSCIENCES INC
3060 Pegasus Park Drive, Building 6
Dallas TEXAS 90502 US
CEO: Paul Wagner
Employees: 11
Company Website: https://www.fortebiorx.com/home/default.aspx
Investor Relations: https://www.fortebiorx.com/investor-relations/
Phone: 13106186994
FORTE BIOSCIENCES INC / FBRX FAQ
What is the stock price of FORTE BIOSCIENCES INC today?
The current stock price of FBRX is 6.5 USD. The price decreased by -7.28% in the last trading session.
What is the ticker symbol for FORTE BIOSCIENCES INC stock?
The exchange symbol of FORTE BIOSCIENCES INC is FBRX and it is listed on the Nasdaq exchange.
On which exchange is FBRX stock listed?
FBRX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for FORTE BIOSCIENCES INC stock?
9 analysts have analysed FBRX and the average price target is 153 USD. This implies a price increase of 2253.85% is expected in the next year compared to the current price of 6.5. Check the FORTE BIOSCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is FORTE BIOSCIENCES INC worth?
FORTE BIOSCIENCES INC (FBRX) has a market capitalization of 41.53M USD. This makes FBRX a Nano Cap stock.
How many employees does FORTE BIOSCIENCES INC have?
FORTE BIOSCIENCES INC (FBRX) currently has 11 employees.
What are the support and resistance levels for FORTE BIOSCIENCES INC (FBRX) stock?
FORTE BIOSCIENCES INC (FBRX) has a resistance level at 16.07. Check the full technical report for a detailed analysis of FBRX support and resistance levels.
Should I buy FORTE BIOSCIENCES INC (FBRX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of FBRX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of FBRX, evaluating the profitability, health, valuation and growth aspects
- FORTE BIOSCIENCES INC (FBRX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- FORTE BIOSCIENCES INC (FBRX) Sales and EPS estimates to see what analysts future expectations are.
- FORTE BIOSCIENCES INC (FBRX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- FORTE BIOSCIENCES INC (FBRX) Insider and Institutional Ownership to learn about the owners and their transactions.
- FORTE BIOSCIENCES INC (FBRX) Stock Chart to make your own analysis
- FORTE BIOSCIENCES INC (FBRX) Latest news and press-releases to stay up to date.
Does FORTE BIOSCIENCES INC (FBRX) stock pay dividends?
FBRX does not pay a dividend.
When does FORTE BIOSCIENCES INC (FBRX) report earnings?
FORTE BIOSCIENCES INC (FBRX) will report earnings on 2025-03-17, after the market close.
What is the Price/Earnings (PE) ratio of FORTE BIOSCIENCES INC (FBRX)?
FORTE BIOSCIENCES INC (FBRX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-19.94).
What is the Short Interest ratio of FORTE BIOSCIENCES INC (FBRX) stock?
The outstanding short interest for FORTE BIOSCIENCES INC (FBRX) is 0.56% of its float. Check the ownership tab for more information on the FBRX short interest.
FBRX Technical Analysis
FBRX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to FBRX. The financial health of FBRX is average, but there are quite some concerns on its profitability.
FBRX Financial Highlights
Over the last trailing twelve months FBRX reported a non-GAAP Earnings per Share(EPS) of -19.94. The EPS decreased by -1525.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -190.54% | ||
| ROE | -365.1% | ||
| Debt/Equity | 0 |
FBRX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to FBRX. The Buy consensus is the average rating of analysts ratings from 9 analysts.